Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vance G Fowler

Showing results (211-220 of 426) with videos related to

Pageof 43
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremiaYu-Ling Chang, Maura Rossetti, David W Gjertson, et al.
Mbio|September 12, 2023
Daily fosfomycin versus levofloxacin for complicated urinary tract infectionsNadine Rouphael, Patricia Winokur, Michael C Keefer, et al.
Cell Reports|June 21, 2018
Salmonella Activation of STAT3 Signaling by SarA Effector Promotes Intracellular Replication and Production of IL-10Sarah L Jaslow, Kyle D Gibbs, W Florian Fricke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged DatabaseJosé M Miro, Ignasi Anguera, Christopher H Cabell, et al.
Plos One|May 25, 2012
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studiesAmy Tong, Steven Y C Tong, Yurong Zhang, et al.
Trials|May 16, 2022
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trialNicholas A Turner, Smitha Zaharoff, Heather King, et al.
Plos One|March 22, 2018
Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trialFleur P Paling, Karina Olsen, Kristin Ohneberg, et al.
Infection Control and Hospital Epidemiology|June 4, 2010
Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedureDeverick J Anderson, Jean Marie Arduino, Shelby D Reed, et al.
The American Journal of Medicine|March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated feverMartin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Infection Control and Hospital Epidemiology|July 16, 2014
Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United StatesJoshua T Thaden, Sarah S Lewis, Kevin C Hazen, et al.
Pageof 43

Showing results (211-220 of 426) with videos related to

Sort By:
Pageof 43
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremiaYu-Ling Chang, Maura Rossetti, David W Gjertson, et al.
Mbio|September 12, 2023
Daily fosfomycin versus levofloxacin for complicated urinary tract infectionsNadine Rouphael, Patricia Winokur, Michael C Keefer, et al.
Cell Reports|June 21, 2018
Salmonella Activation of STAT3 Signaling by SarA Effector Promotes Intracellular Replication and Production of IL-10Sarah L Jaslow, Kyle D Gibbs, W Florian Fricke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged DatabaseJosé M Miro, Ignasi Anguera, Christopher H Cabell, et al.
Plos One|May 25, 2012
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studiesAmy Tong, Steven Y C Tong, Yurong Zhang, et al.
Trials|May 16, 2022
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trialNicholas A Turner, Smitha Zaharoff, Heather King, et al.
Plos One|March 22, 2018
Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trialFleur P Paling, Karina Olsen, Kristin Ohneberg, et al.
Infection Control and Hospital Epidemiology|June 4, 2010
Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedureDeverick J Anderson, Jean Marie Arduino, Shelby D Reed, et al.
The American Journal of Medicine|March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated feverMartin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Infection Control and Hospital Epidemiology|July 16, 2014
Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United StatesJoshua T Thaden, Sarah S Lewis, Kevin C Hazen, et al.
Pageof 43